Skip to main content
Livermore
Livermore
ZHEN

IFG Advisory, LLC

SEC CIK
0001728319
Latest filing
Aug 13, 2026

GSK holding history

GSK plc in every 13F filed by IFG Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
16,758
Value
$878.5K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of GSK by IFG Advisory, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,758$878.5K<0.1%+16,758NewHolders
Q1 20260$00.0%−17,738−100.0%Sold outHolders
Q4 202517,738$869.9K<0.1%−893−4.8%ReducedHolders
Q3 202518,631$804.1K<0.1%−77−0.4%ReducedHolders
Q2 202518,708$718.4K<0.1%+991+5.6%AddedHolders
Q1 202517,717$686.4K<0.1%+1,624+10.1%AddedHolders
Q4 202416,093$544.3K<0.1%−176−1.1%ReducedHolders
Q3 202416,269$665.1K<0.1%+1,664+11.4%AddedHolders
Q2 202414,605$562.3K<0.1%+1,638+12.6%AddedHolders
Q1 202412,967$555.9K<0.1%−1,368−9.5%ReducedHolders
Q4 202314,335$531.3K<0.1%−2,637−15.5%ReducedHolders
Q3 202316,972$615.3K0.1%−2,452−12.6%ReducedHolders
Q2 202319,424$692.3K0.1%+1,561+8.7%AddedHolders
Q1 202317,863$635.6K0.1%−3,580−16.7%ReducedHolders
Q4 202221,443$753.0K0.1%−82−0.4%ReducedHolders
Q3 202221,525$633.0K0.1%+7,257+50.9%AddedHolders
Q2 202214,268$621.0K0.1%−15,991−52.8%ReducedHolders
Q1 202230,259$1.32M0.1%−1,308−4.1%ReducedHolders
Q4 202131,567$1.39M0.1%+901+2.9%AddedHolders
Q3 202130,666$1.17M0.1%+6,681+27.9%AddedHolders
Q2 202123,985$955.0K0.1%+16,753+231.7%AddedHolders
Q1 20217,232$258.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.